Ham salad products recalled due to possible listeria: USDA
Newly Weds Foods announced it is recalling Reser's Fine Foods Ham Salad and Molly's Kitchen Ham Salad, the products in question.
'The problem was discovered when Reser's Fine Foods, Inc., a Topeka, Kansas, establishment, determined that they used FDA-regulated breadcrumb products subject to an FDA recall because the breadcrumbs may be contaminated with [listeria monocytogenes],' the agency said in a press release.
It's just the latest recall announcement tied to Reser's Fine Foods products made with potentially tainted bread crumbs.
Albertsons recently announced a pair of recalls linked to tuna salad products made with breadcrumbs. The states included in those announcements were Illinois, Indiana, Iowa, Texas, Arkansas, Louisiana and Oklahoma.
Thus far, there have been no confirmed reports of anyone getting ill from consuming the products.
Anybody who consumes food contaminated with listeria is at risk of listeriosis, a serious infection that affects older adults, people with weakened immune systems, pregnant women and their babies.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
John Cena, 48, says getting this cosmetic procedure 'completely changed' his life
John Cena, 48, wrestled with hair loss for years, but this cosmetic procedure gave him his confidence back. In an interview with People published on Wednesday, Cena spoke about retiring from the WWE and the realities of aging, including his experience with hair loss. "As I was trying to hide my hair loss, the audience was bringing it to light," he told People. "I saw their signs that said 'The bald John Cena.'" The 17-time WWE world champion said the public scrutiny around his appearance "pushed him" to find ways to deal with hair loss. "I now have a routine: red-light therapy, minoxidil, vitamins, shampoo, conditioner — and I also got a hair transplant last November," Cena said. "I hate the fact that if there wasn't so much shame around it, I'd have gotten it done 10 years ago." The wrestler said he thought he was "alone" in his struggle, but eventually realized how common hair loss was among men. The procedure was simple, Cena said: "They don't do anything except move your hair, one by one, from one area to another." He added that he isn't embarrassed to talk about his hair transplant experience. "If somebody's going to sweat me for that, I don't think there's any shame in that," Cena said. "It completely changed the course of my life." As he looks beyond wrestling, he believes a fuller hairline might help him land a broader range of roles. "A different hairstyle can identify a part that can get me more work, do the thing I love to do," he added. A representative for Cena did not immediately respond to a request for comment sent by Business Insider outside regular hours. Male pattern baldness, or androgenetic alopecia, accounts for over 95% of hair loss in men, per data from the American Hair Loss Association, a nonprofit organization. Around 25% of men with male pattern baldness start losing hair before age 21. There are two FDA-approved medications for male pattern baldness, while other treatment options include laser therapy, platelet-rich plasma, and hair transplants. In recent years, Turkey has made a name for itself as the go-to destination for hair transplant surgery. Around one million people traveled to Turkey for hair transplants in 2022, the head of the Turkish Health Tourism Association told local news agency Anadolu. There's also been a trend of white-collar men in the US spending thousands on plastic surgery, fillers, and other self-care routines to look good, especially at work. Data from the 2023 American Society of Plastic Surgeons procedural statistics report showed that men accounted for 6% of cosmetic procedures overall. In 2023, facelifts among men rose by 17%, nose reshaping increased by 10%, and eyelid surgery increased by 9% compared to the previous year.
Yahoo
4 hours ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Newsweek
4 hours ago
- Newsweek
Ice Cream Recall Map Shows States With New Warning
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. DFA Dairy Brands, LLC, is recalling the Friendly's brand of Cookies & Cream ice cream due to undeclared soy and wheat concerns. Newsweek reached out to the company via email on Wednesday for comment. Why It Matters Numerous recalls have been initiated this year due to the potential for damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. People with a wheat or soy allergy could experience a "serious or life-threatening allergic reaction if they consume these products," the FDA warns. What To Know In the alert, the FDA says that the recalled products were packaged mistakenly in Friendly's Vanilla Bean cartons with a Cookies & Cream lid. The recalled products were distributed through UNFI to retail locations in Pennsylvania, Maryland and Virginia. Below is a map showing the states impacted by the recall: The ice cream was sold in 48-fluid ounce containers with a best-by date of November 26, 2025. No other Friendly's products are impacted by the recall, the FDA alert notes. What People Are Saying The FDA in the alert, in part: "The voluntary recall was initiated after it was discovered that a limited quantity of Cookies & Cream ice cream was mistakenly packaged in Friendly's Vanilla Bean ice cream cartons that did not identify the soy and wheat ingredients. No illnesses or adverse reactions have been reported. This recall is being made with the knowledge of the U.S. Food and Drug Administration." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall; the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall. "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled product are urged to return the ice cream to the original place of purchase for a refund, the FDA alert notes. People with additional questions may contact DFA Dairy Brands, LLC, via phone at 800- 587-2259. Further recalls or updates are possible as investigations continue, and consumers are encouraged to monitor FDA alerts for developments.
